Free Trial

Soleno Therapeutics (SLNO) SEC Filings & 10K Form

Soleno Therapeutics logo
$86.00 -0.47 (-0.54%)
Closing price 08/1/2025 04:00 PM Eastern
Extended Trading
$87.00 +1.00 (+1.16%)
As of 08/1/2025 07:37 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Soleno Therapeutics SEC Filings

DateFilerForm TypeView
07/17/2025
7:12 PM
BlackRock, Inc. (Filed by)
Soleno Therapeutics (Subject)
Form SCHEDULE 13G
07/10/2025
8:43 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/10/2025
8:45 PM
Soleno Therapeutics (Filer)
Form 424B5
07/10/2025
5:05 AM
Soleno Therapeutics (Filer)
Form 424B5
07/10/2025
5:10 AM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/03/2025
3:41 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/26/2025
5:04 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
6:19 PM
Bir Dawn Carter (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
6:20 PM
Harris William G (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
6:21 PM
Pauls Matthew (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
6:25 PM
Sinclair Andrew (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/09/2025
6:27 PM
Soleno Therapeutics (Issuer)
Volck Birgitte (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2025
11:02 AM
JANUS HENDERSON GROUP PLC (Filed by)
Soleno Therapeutics (Subject)
Form SCHEDULE 13G/A
05/14/2025
9:45 AM
PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Soleno Therapeutics (Subject)
Form SCHEDULE 13G
05/12/2025
8:06 AM
Adage Capital Management, L.P. (Filed by)
Soleno Therapeutics (Subject)
Form SCHEDULE 13G/A
04/30/2025
4:15 PM
Nantahala Capital Management, LLC (Filed by)
Soleno Therapeutics (Subject)
Form SCHEDULE 13G/A
04/22/2025
3:49 PM
Soleno Therapeutics (Filer)
Form DEF 14A
04/22/2025
3:52 PM
Soleno Therapeutics (Filer)
Form DEFA14A
04/22/2025
3:54 PM
Soleno Therapeutics (Filer)
Form ARS
04/02/2025
4:38 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2025
7:00 PM
Soleno Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
Form SCHEDULE 13G/A
03/31/2025
6:18 PM
Huang Michael F. (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2025
6:20 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2025
6:21 PM
Manning Meredith (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2025
6:23 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2025
6:24 PM
Pauls Matthew (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2025
6:00 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/31/2025
6:01 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
6:03 PM
Soleno Therapeutics (Issuer)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/28/2025
11:45 AM
Pauls Matthew (Reporting)
Soleno Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/27/2025
7:53 AM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/27/2025
7:54 AM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/27/2025
7:55 AM
Huang Michael F. (Reporting)
Soleno Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/27/2025
7:55 AM
Mackaness James H (Reporting)
Soleno Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/27/2025
7:56 AM
Manning Meredith (Reporting)
Soleno Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/27/2025
7:57 AM
Soleno Therapeutics (Subject)
Yen Kristen (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/26/2025
4:00 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/28/2025
3:31 PM
Soleno Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/28/2025
8:22 AM
Soleno Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2025
3:30 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2025
10:56 AM
JANUS HENDERSON GROUP PLC (Filed by)
Soleno Therapeutics (Subject)
Form SCHEDULE 13G/A
This Social Security Shift Could Boost Benefits by 400% (Ad)

If you currently collect Social Security—or plan to in the future—this may be one of the most important updates you'll ever see. A new initiative, linked to President Trump's Executive Order #14196, has the potential to do more than just protect Social Security from collapse... According to renowned investor Louis Navellier, it could increase benefits by as much as 400%.

Click here to watch the urgent briefing now — before this opportunity disappears.
02/12/2025
8:34 AM
ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Soleno Therapeutics (Subject)
Form SCHEDULE 13G/A
02/05/2025
4:28 PM
BlackRock, Inc. (Filed by)
Soleno Therapeutics (Subject)
Form SCHEDULE 13G/A
01/23/2025
3:22 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:24 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:25 PM
Huang Michael F. (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:27 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:28 PM
Manning Meredith (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/23/2025
3:29 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
8:55 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
8:56 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
8:56 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
8:57 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2024
3:30 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/26/2024
7:46 AM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/19/2024
8:44 PM
PERCEPTIVE ADVISORS LLC (Filed by)
Soleno Therapeutics (Subject)
Form SC 13D/A
11/14/2024
3:53 PM
Nantahala Capital Management, LLC (Filed by)
Soleno Therapeutics (Subject)
Form SCHEDULE 13G/A
11/14/2024
8:36 AM
Avoro Capital Advisors LLC (Filed by)
Soleno Therapeutics (Subject)
Form SC 13G
11/12/2024
8:33 AM
Adage Capital Management, L.P. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13G/A
11/06/2024
3:06 PM
Soleno Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2024
3:44 PM
BlackRock, Inc. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13G
10/21/2024
3:30 PM
Abingworth Bioventures VII LP (Reporting)
Soleno Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/21/2024
3:31 PM
Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13D/A
10/15/2024
3:31 PM
Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13D/A
10/10/2024
3:30 PM
Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13D/A
10/03/2024
4:53 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
4:55 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
5:02 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
5:03 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/03/2024
8:55 AM
JANUS HENDERSON GROUP PLC (Filed by)
Soleno Therapeutics (Subject)
Form SC 13G
09/10/2024
5:30 PM
Carlyle Group Inc. (Filed by)
Carlyle Group Inc. (Filed by)
Soleno Therapeutics (Subject)
Form SC 13D/A
09/05/2024
5:37 PM
Soleno Therapeutics (Subject)
Vivo Opportunity Fund Holdings, L.P. (Filed by)
Form SC 13G
08/30/2024
5:33 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
5:34 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
5:35 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/30/2024
5:36 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/29/2024
6:36 PM
Soleno Therapeutics (Issuer)
Vivo Opportunity Fund Holdings, L.P. (Reporting)
Vivo Opportunity, LLC (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/23/2024
6:14 PM
Soleno Therapeutics (Issuer)
Urbanski Raymond W. (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/23/2024
6:16 PM
Soleno Therapeutics (Issuer)
Urbanski Raymond W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/16/2024
5:16 PM
Bir Dawn Carter (Reporting)
Soleno Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
08/16/2024
5:18 PM
Bir Dawn Carter (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
5:55 PM
Anish Bhatnagar (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
5:56 PM
Hirano Patricia C (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
5:56 PM
Mackaness James H (Reporting)
Soleno Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
5:57 PM
Soleno Therapeutics (Issuer)
Yen Kristen (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2024
4:18 PM
Soleno Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
3:54 PM
Soleno Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
08/07/2024
3:00 PM
Soleno Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:SLNO) was last updated on 8/2/2025 by MarketBeat.com Staff
From Our Partners